Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Johanne, Daupin"'
Autor:
Hadrien Alric, Eric Caudron, Arthur Berger, Johanne Daupin, Guillaume Perrod, Claire Wilhelm, Florence Gazeau, Amanda K.A. Silva, Gabriel Rahmi
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 46:101990
Autor:
Julie Fillon, Daniele G. Soares, Pascal Paubel, Isabelle Debrix, Jean-Pierre Lotz, Johanne Daupin
Publikováno v:
Journal of Chemotherapy. 28:494-499
The active clinical research programme of trabectedin continues to improve knowledge on the therapeutic activity and toxicity of the drug in the treatment of soft tissue sarcomas (STS). In contrast, limited number of data is available on its use outs
Autor:
Jean-François Bussières, Johanne Daupin, Suzanne Atkinson, Pascal Bédard, Denis Lebel, Véronique Pelchat
Publikováno v:
Journal of Evaluation in Clinical Practice. 22:911-920
Rationale, aims and objectives The medication-use system in hospitals is very complex. To improve the health professionals' awareness of the risks of errors related to the medication-use system, a simulation of medication errors was created. The main
Autor:
Eric Caudron, Germain Perrin, Brigitte Sabatier, Chloe Lhermitte-Pastor, Simon Pernot, Virginie Savoldelli, Marie-Caroline Loustalot, Constance Thibault, Bruno Landi, Johanne Daupin
Publikováno v:
Journal of Oncology Pharmacy Practice
Journal of Oncology Pharmacy Practice, SAGE Publications, 2018, 25 (5), pp.1195-1203. ⟨10.1177/1078155219826344⟩
Journal of Oncology Pharmacy Practice, SAGE Publications, 2018, 25 (5), pp.1195-1203. ⟨10.1177/1078155219826344⟩
Cancer chemotherapy is a high-risk process. To improve patient safety, a systematic pharmaceutical analysis of chemotherapy prescriptions is performed in our institution. The aim of this study was to assess the impact of pharmaceutical interventions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d4e5215706f356c1bea05b2ed9c0c42
https://hal.archives-ouvertes.fr/hal-03349547
https://hal.archives-ouvertes.fr/hal-03349547
Publikováno v:
Journal of Cancer Policy
Journal of Cancer Policy, 2017, 12, pp.55-60. ⟨10.1016/j.jcpo.2017.03.011⟩
Journal of Cancer Policy, 2017, 12, pp.55-60. 〈10.1016/j.jcpo.2017.03.011〉
Journal of Cancer Policy, Elsevier, 2017, 12, pp.55-60. ⟨10.1016/j.jcpo.2017.03.011⟩
Journal of Cancer Policy, 2017, 12, pp.55-60. ⟨10.1016/j.jcpo.2017.03.011⟩
Journal of Cancer Policy, 2017, 12, pp.55-60. 〈10.1016/j.jcpo.2017.03.011〉
Journal of Cancer Policy, Elsevier, 2017, 12, pp.55-60. ⟨10.1016/j.jcpo.2017.03.011⟩
International audience; The development of new anticancer drugs has strongly contributed to improve patients’ outcomes. However, the question can be raised whether the sometimes minor benefits are worth the cost to both the individuals and the soci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1b726bec550d18faa3d8bfe03a901e7
https://hal.sorbonne-universite.fr/hal-01501359
https://hal.sorbonne-universite.fr/hal-01501359
Autor:
Hélène Levert, Charlotte Debraine, Nathalie Jourdan, Pierre Faure, Valentin Breteau, Nolwenn Robert, Delphine Constant, Johanne Daupin
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 49:318-319
Introduction Lors de la reconstitution d’anticancereux, les bonnes pratiques de preparation recommandent l’utilisation de prises d’air, afin d’eviter une aerosolisation. Suite au referencement d’une nouvelle prise d’air (Didactic), l’un
Autor:
Catherine Roux, Pierre Faure, Hélène Levert, Élisabeth Rouimi, Nathalie Jourdan, Marie Battistella, Guillaume Ventroux, Johanne Daupin, Layla Ouagoni
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 49:335
Introduction Afin d’eviter l’aerosolisation d’anticancereux, les unites de preparation utilisent des prises d’air ou des perforateurs securises (dits spikes) de facon systematique. En raison d’une activite importante (environ 420 flacons/jo